BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36496335)

  • 41. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
    Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
    [No Abstract]   [Full Text] [Related]  

  • 43. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers.
    Lee HY; Jeong JY; Lee KS; Kim HJ; Han J; Kim BT; Kim J; Shim YM; Kim JH; Song I
    Radiology; 2012 Sep; 264(3):884-93. PubMed ID: 22829686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controversies on lung cancers manifesting as part-solid nodules.
    Yip R; Li K; Liu L; Xu D; Tam K; Yankelevitz DF; Taioli E; Becker B; Henschke CI
    Eur Radiol; 2018 Feb; 28(2):747-759. PubMed ID: 28835992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
    Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
    Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
    Shiono S; Abiko M; Sato T
    J Thorac Oncol; 2011 Jan; 6(1):43-7. PubMed ID: 21079522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of TSCT Features for Differentiating Preinvasive and Minimally Invasive Adenocarcinoma From Invasive Adenocarcinoma Presenting as Subsolid Nodules Smaller Than 3 cm.
    Wang H; Weng Q; Hui J; Fang S; Wu X; Mao W; Chen M; Zheng L; Wang Z; Zhao Z; Zhou L; Tu J; Xu M; Huang Y; Ji J
    Acad Radiol; 2020 Mar; 27(3):395-403. PubMed ID: 31201034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
    Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What are the radiologic findings predictive of indolent lung adenocarcinoma?
    Mimae T; Miyata Y; Tsutani Y; Mimura T; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Apr; 45(4):367-72. PubMed ID: 25628349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
    Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
    Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
    Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lung Adenocarcinoma Manifesting as Ground-Glass Opacity Nodules 3 cm or Smaller: Evaluation With Combined High-Resolution CT and PET/CT Modality.
    Niu R; Shao X; Shao X; Wang J; Jiang Z; Wang Y
    AJR Am J Roentgenol; 2019 Nov; 213(5):W236-W245. PubMed ID: 31361533
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
    Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M
    Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma.
    Wang XY; Zhao YF; Liu Y; Yang YK; Wu N
    Medicine (Baltimore); 2017 Sep; 96(35):e7941. PubMed ID: 28858121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma.
    Hashinokuchi A; Haratake N; Takenaka T; Matsudo K; Nagano T; Watanabe K; Kosai K; Oku Y; Ono Y; Takamori S; Kohno M; Baba S; Ishigami K; Yoshizumi T
    Thorac Cancer; 2022 Sep; 13(18):2624-2632. PubMed ID: 35962578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection.
    Ibuki Y; Tsutani Y; Miyata Y; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2017 Feb; 47(2):157-163. PubMed ID: 28173177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
    Shiono S; Abiko M; Sato T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Progress in diagnosis and treatment of lung adenocarcinomas imaging manifesting as radiological part-solid nodule].
    Bai GY; Qiu B; Ji Y; Song P; Zhang F; Xue Q; Gao SG
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):743-750. PubMed ID: 34289567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
    Murakami S; Saito H; Sakuma Y; Kondo T; Oshita F; Ito H; Tsuboi M; Hasegawa C; Yokose T; Kameda Y; Nakayama H; Yamada K
    Eur J Radiol; 2012 Aug; 81(8):1891-5. PubMed ID: 21546177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.